✨
AI Summary
- Bayer is strategically reducing debt.
- AbbVie appoints an internal CEO.
- Denali/Sanofi face another RIPK1 setback.
Guests on This Episode
EC
ex-Daiichi Sankyo CEO
1 podcast appearance